Valuation multiples, financial metrics, and company listings for the Materials sector.
P25: 14.6 / P75: 32.3
P25: 1.3 / P75: 5.2
P25: 9.2 / P75: 22.6
P25: -27.4% / P75: 15.0%
| Ticker | Name | Market Cap |
|---|---|---|
| LLY | ELI LILLY & Co | $985.4B |
Data updated daily · Source: SEC EDGAR, Polygon.io
| JNJ | Johnson & Johnson | $542.4B |
| ABBV | AbbVie Inc. | $384.7B |
| PG | PROCTER & GAMBLE CO | $334.3B |
| MRK | Merck & Co., Inc. | $293.2B |
| LIN | LINDE PLC | $230.1B |
| AMGN | Amgen Inc. | $181.8B |
| GILD | GILEAD SCIENCES, INC. | $166.9B |
| PFE | Pfizer Inc. | $149.2B |
| ABT | ABBOTT LABORATORIES | $149.1B |
| BMY | Bristol-Myers Squibb Company | $116.8B |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $113.6B |
| CRH | CRH public limited company | $72.7B |
| CL | COLGATE-PALMOLIVE COMPANY | $72.1B |
| ECL | ECOLAB INC. | $72.0B |
| NKE | NIKE, Inc. | $68.5B |
| REGN | REGENERON PHARMACEUTICALS, INC. | $64.5B |
| APD | AIR PRODUCTS AND CHEMICALS, INC. | $62.0B |
| IDXX | IDEXX LABORATORIES INC /DE | $44.5B |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | $41.1B |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $40.3B |
| KVUE | Kenvue Inc. | $33.2B |
| NTR | NUTRIEN LTD. | $32.9B |
| ZTS | Zoetis Inc. | $32.6B |
| KMB | KIMBERLY-CLARK CORPORATION | $32.4B |
| EL | Estee Lauder Companies Inc | $32.2B |
| AMRZ | Amrize Ltd | $30.1B |
| BIIB | BIOGEN INC. | $28.9B |
| PPG | PPG INDUSTRIES INC | $25.2B |
| DOW | Dow Inc. | $24.3B |
| UTHR | United Therapeutics Corporation | $23.6B |
| INSM | INSMED INC | $23.2B |
| CHD | CHURCH & DWIGHT CO., INC. | $22.7B |
| SW | Smurfit Westrock plc | $21.6B |
| LYB | LYONDELLBASELL INDUSTRIES N.V. | $21.5B |
| ENTG | Entegris, Inc. | $21.1B |
| ALB | Albemarle Corporation | $20.8B |
| DD | DUPONT DE NEMOURS, INC. | $19.6B |
| PKG | PACKAGING CORP OF AMERICA | $19.5B |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $19.4B |
| VTRS | VIATRIS INC. | $18.9B |
| MRNA | Moderna, Inc. | $18.7B |
| IP | INTERNATIONAL PAPER COMPANY | $17.7B |
| CF | CF INDUSTRIES HOLDINGS, INC. | $17.3B |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | $15.9B |
| JAZZ | Jazz Pharmaceuticals plc | $14.8B |
| ONON | On Holding AG | $14.2B |
| CSL | CARLISLE COMPANIES INCORPORATED | $14.0B |
| RPM | RPM International Inc. | $13.5B |
| SOLS | Solstice Advanced Materials Inc. | $13.4B |